Literature DB >> 6509317

GABAergic agents in the medial septal nucleus affect hippocampal theta rhythm and acetylcholine utilization.

C N Allen, I L Crawford.   

Abstract

Neurons of the medial septal nucleus are important in regulating the physiological activity of the hippocampus. If intraseptal injection of putative neurotransmitter substances affects the turnover rate of hippocampal acetylcholine, then concomitant changes would be expected in the electrophysiologic activity of the hippocampus. A GABA agonist, muscimol, was injected into the medial septum of rats and the effects on hippocampal electrical activity and acetylcholine utilization were studied. The intraseptally injected muscimol (100 ng) resulted in hippocampal electrographic records containing low amplitude asynchronous waves and significantly less rhythmic slow activity (RSA, 6-9 Hz), compared to control injections of saline. This effect was antagonized by prior intraseptal injection of bicuculline (3 micrograms). The hippocampal electrical activity returned to normal within 100 min. The utilization of acetylcholine was significantly reduced by intraseptal muscimol at times after administration when electrographic activity was also altered, and spontaneous behavioral movement was increased. These results suggest a physiological connection between hippocampal RSA generation and GABAergic mechanisms in the septum.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6509317     DOI: 10.1016/0006-8993(84)90116-1

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  15 in total

1.  GABAergic presubicular projections to the medial entorhinal cortex of the rat.

Authors:  T van Haeften; F G Wouterlood; B Jorritsma-Byham; M P Witter
Journal:  J Neurosci       Date:  1997-01-15       Impact factor: 6.167

2.  The lateral septum as a regulator of hippocampal theta oscillations and defensive behavior in rats.

Authors:  San-San A Chee; Janet L Menard; Hans C Dringenberg
Journal:  J Neurophysiol       Date:  2015-01-14       Impact factor: 2.714

Review 3.  Deep brain stimulation for the treatment of disorders of consciousness and cognition in traumatic brain injury patients: a review.

Authors:  Bornali Kundu; Andrea A Brock; Dario J Englot; Christopher R Butson; John D Rolston
Journal:  Neurosurg Focus       Date:  2018-08       Impact factor: 4.047

Review 4.  Brain reward circuitry beyond the mesolimbic dopamine system: a neurobiological theory.

Authors:  Satoshi Ikemoto
Journal:  Neurosci Biobehav Rev       Date:  2010-02-10       Impact factor: 8.989

5.  Theta Oscillations during Active Sleep Synchronize the Developing Rubro-Hippocampal Sensorimotor Network.

Authors:  Carlos Del Rio-Bermudez; Jangjin Kim; Greta Sokoloff; Mark S Blumberg
Journal:  Curr Biol       Date:  2017-05-04       Impact factor: 10.834

6.  Site-specific enhancement of gamma-aminobutyric acid-mediated inhibition of neural activity by ethanol in the rat medial septal area.

Authors:  B S Givens; G R Breese
Journal:  J Pharmacol Exp Ther       Date:  1990-08       Impact factor: 4.030

7.  Self-administration of the GABAA agonist muscimol into the medial septum: dependence on dopaminergic mechanisms.

Authors:  Stéphanie Gavello-Baudy; Julie Le Merrer; Laurence Decorte; Vincent David; Pierre Cazala
Journal:  Psychopharmacology (Berl)       Date:  2008-08-01       Impact factor: 4.530

8.  Enhancement of acetylcholine release by flumazenil in the hippocampus of rats chronically treated with diazepam but not with imidazenil or abecarnil.

Authors:  L Dazzi; C Motzo; G Maira; A Sanna; M Serra; G Biggio
Journal:  Psychopharmacology (Berl)       Date:  1995-09       Impact factor: 4.530

9.  The memory-impairing effects of septal GABA receptor activation involve GABAergic septo-hippocampal projection neurons.

Authors:  Desiree L Krebs-Kraft; Marina G Wheeler; Marise B Parent
Journal:  Learn Mem       Date:  2007-12-17       Impact factor: 2.460

10.  Artificial theta stimulation impairs encoding of contextual fear memory.

Authors:  Arto Lipponen; Bisrat T Woldemichael; Kestutis Gurevicius; Heikki Tanila
Journal:  PLoS One       Date:  2012-11-01       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.